ScholarIQanswers from OpenAlex
Anti-Cancer Nanomedicines: A Revolution of Tumor Immunotherapy
PaperCitations, authors & open-access status
Anti-Cancer Nanomedicines: A Revolution of Tumor Immunotherapy is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Anti-Cancer Nanomedicines: A Revolution of Tumor Immunotherapy have?
ScholarIQcitation count
Anti-Cancer Nanomedicines: A Revolution of Tumor Immunotherapy has 29 citations in the OpenAlex counts ScholarIQ stores.
When was Anti-Cancer Nanomedicines: A Revolution of Tumor Immunotherapy published?
ScholarIQyear
Anti-Cancer Nanomedicines: A Revolution of Tumor Immunotherapy has 2020 year in the ScholarIQ index.
What is the open-access status of Anti-Cancer Nanomedicines: A Revolution of Tumor Immunotherapy?
ScholarIQoa status
Anti-Cancer Nanomedicines: A Revolution of Tumor Immunotherapy has gold oa status in the ScholarIQ index.
What is the DOI of Anti-Cancer Nanomedicines: A Revolution of Tumor Immunotherapy?
ScholarIQdoi
The DOI for Anti-Cancer Nanomedicines: A Revolution of Tumor Immunotherapy is on the source record.
What is the PMID of Anti-Cancer Nanomedicines: A Revolution of Tumor Immunotherapy?
ScholarIQpmid
The PMID for Anti-Cancer Nanomedicines: A Revolution of Tumor Immunotherapy is on the source record.
What is the OpenAlex record for Anti-Cancer Nanomedicines: A Revolution of Tumor Immunotherapy?
ScholarIQopenalex
The OpenAlex for Anti-Cancer Nanomedicines: A Revolution of Tumor Immunotherapy is on the source record.